Senator Bill Bradley Joins Board of Envoy Therapeutics

Envoy Therapeutics, Inc., a newly formed drug discovery company focused on neurological and psychiatric diseases, today announced that former Senator Bill Bradley has joined its Board of Directors.

“We’re thrilled to welcome a national leader who is well known for his hard work, vision and candor,” said Brad Margus, Co-founder and Chief Executive Officer of Envoy. “Our company will benefit greatly from the corporate governance experience the Senator has gained serving on numerous public and private boards. His knowledge of healthcare issues and the drug industry will be an invaluable resource.”

“Few start-up companies boast such a strong combination of world-class scientists, seasoned executives and top-tier investors involved at such an early stage,” added Bill Bradley. “I’m eager to participate in the company’s emergence as a next-generation drug discovery company with a remarkable technology and the promise of helping millions of people who suffer from brain-related diseases.”

Senator Bradley is a Managing Director of Allen & Company LLC and is also a member of the Boards of Starbucks Corp., Seagate Technologies and Willis Group Holdings. From 2001 to 2004, he acted as chief outside advisor to McKinsey & Company’s non-profit practice. He was a Senior Advisor and Vice Chairman of the International Council of JP Morgan & Co., Inc. from 1997 to 1999. During that time, he also worked as an essayist for CBS evening news and as a visiting professor at Stanford University, Notre Dame University and the University of Maryland.

Senator Bradley served in the United States Senate from 1979 to 1997 representing the state of New Jersey. In 2000, he was a candidate for the President of the United States. Prior to serving in the Senate, he was an Olympic gold medalist in 1964 and a professional basketball player with the New York Knicks from 1967 to 1977 during which time the team won two NBA championships.

Senator Bradley holds a B.A. degree in American History from Princeton University and an MA degree from Oxford University where he was a Rhodes Scholar. He has authored six books on American politics, culture and economy. Currently, Senator Bradley hosts American Voices, a weekly show on Sirius Radio that highlights the remarkable accomplishments of Americans both famous and unknown.

About Envoy Therapeutics

Envoy Therapeutics’ mission is to discover new drugs with superior efficacy and fewer side effects than existing treatments. The company’s bacTRAP^® technology enables the identification of proteins in vivo that are produced by specific cell types without requiring the isolation of those cells. The technology is especially powerful in tissues of the brain, where many hundreds of cell types are intermingled. Because therapeutically modulating the activity of a specific cell type has until now been prevented by the inability to determine which proteins are uniquely expressed by that cell type, Envoy brings a new day in drug discovery.